In general, transfer of the results of the scientific literature to clinical practice takes place very slowly. GISSI has accelerated this process: currently, the use of thrombolysis in patients with acute myocardial infarction is widespread (GISSI-3 data) and surely more common than that observed in CCUs in the USA and in Canada.